Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment

Cannabidiol (CBD), a lipophilic cannabinoid compound without psychoactive effects, has emerged as adjuvant of anti-epileptic drugs (AEDs) in the treatment of refractory epilepsy (RE), decreasing the severity and/or frequency of seizures. CBD is considered a multitarget drug that could act throughout...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Claudia Taborda, Lairion, Fabiana, Repetto, Marisa, Ettcheto, Miren, Merelli, Amalia, Lazarowski, Alberto, Auzmendi, Jerónimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001508/
https://www.ncbi.nlm.nih.gov/pubmed/33807975
http://dx.doi.org/10.3390/ph14030220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001508/
https://www.ncbi.nlm.nih.gov/pubmed/33807975
http://dx.doi.org/10.3390/ph14030220

Ejemplares similares